Skip to main content
Emma Duncan on Muck Rack

Emma Duncan

Verified
United Kingdom
As seen in: The Times, Nature, The Economist, Yahoo Finance, Manawatū Standard, The Conversation, The Nelson Mail, The Sunday Times, Yahoo, The Herald (Glasgow), Cell Press and
Columnist, The Times. Recommendations of slightly obscure novels more than a century old gratefully received
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Emma

Contact Emma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Multiscale analysis and functional validation of the cellular and genetic determinants of skeletal disease

|
By Ryan C. Chai, Mischa Lundberg, Bernard Freudenthal, James Smith, Andrew Boughton, Kaitlyn Flynn, Monika Frysz, Weng Hua Khoo, Davide Komla-Ebri, Siobhan E. Guilfoyle, John Logan, Natalie C. Butterfield, Victoria Leitch, Andrea Pollard, Lorenzo Ramos-Mucci, Amaia Vilas-Zornoza, Yunshun Chen, Raymond Yip, Jeremy Er, Siew Zhuan Tan, Michelle McDonald, Scott E Youlten, C. Sergio, Ariel Castro-Martinez, Shelley Young, Elena Y. Skorokhodova, David Evans, Joseph Powell, Christiaan de Leeuw, Adam Ewing, John Eisman, Robert Blank, Tri Giang Phan, Anne K. Lagendijk, Edwin Hawkins, Rebecca McIntyre, Edith Hessel, Jake P. Taylor-King, Emma Duncan Verified, Graham Williams, Peter Croucher, John Kemp, Yuandan Zhang, Alexander P. Corr, Michael R. G. Dack, Riikka E. Mäkitie, Nathaniel Bradford, Horng Lii Oh, Paul A. Baldock, J. H. Duncan Bassett
| Nature Verified
Abstract Musculoskeletal diseases are a major health burden. Development of bone-active therapies has been hindered by limited understanding of the cells and genes that regulate the skeleton. We exploited the value of cross-species analysis and developed single-cell methodologies in skeletal tissues to define the critical endosteal compartment that regulates bone turnover.
Open in Who Shared Issue with article?

How Your Quantum Stock Faves Perform After Major Bull Gaps

|
By Emma Duncan Verified
| Schaeffer's Investment Research
Subscribers to Chart of the Week received this commentary on Sunday, May 24. We’ve published several brief check-ins for the quantum computing sector this week, as the news cycle has been plentiful in providing catalysts for those betting on a continued rise in the segment. On Thursday the U.S. Department of Commerce awarded a funding grant worth $2 billion to nine quantum companies, including an equity stake in several.
Open in Who Shared View Duplicates (2) Issue with article?

Data Center Stock Flashing Intriguing "Buy" Signal

|
By Emma Duncan Verified
| Yahoo Finance Verified
Data center stock IREN Ltd (NASDAQ:IREN) is up 9.1% to trade at $46.97 today, headed for an eighth-straight win as part of the broader tech sector rally. IREN is up 715% year over year, but has taken a 38% haircut off its Nov. 5 all-time high of $76.87. This recent rally could have staying power, with IREN clearing a historically bullish trendline. The trendline in question is the stock's 50-day moving average.
Open in Who Shared View Duplicates (3) Issue with article?
See all 138 licensed articles (166 Total)